STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] OMNICELL, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Omnicell, Inc. (OMCL) reported an equity award to its Executive Vice President & Chief Financial Officer, H. Baird Radford III, on a Form 4. On 11/15/2025, he received 32,932 shares of Omnicell common stock in the form of restricted stock units granted under the company’s equity incentive plan at a stated price of $0 per share, reflecting a stock-based award rather than a cash purchase. After this grant, he beneficially owns 32,932 shares directly. The award vests over time: 25% of the shares are scheduled to vest on November 15, 2026, and the remaining 75% vest in equal quarterly installments over three years on 2/15, 5/15, 8/15, and 11/15, aligning his compensation with longer-term company performance.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Radford Harlan Baird

(Last) (First) (Middle)
4220 NORTH FREEWAY

(Street)
FORT WORTH TX 76137

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMNICELL, INC. [ OMCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/15/2025 A 32,932(1) A $0 32,932 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on November 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 2/15; (ii) 05/15; (iii) 8/15; and (iv) 11/15.
/s/ Vijay Biligiri, Attorney-in-Fact for H. Baird Radford, III 11/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Omnicell (OMCL) disclose in this Form 4 filing?

Omnicell reported that its EVP & Chief Financial Officer, H. Baird Radford III, received a grant of 32,932 restricted stock units (RSUs) of Omnicell common stock on 11/15/2025 under the company’s equity incentive plan.

How many Omnicell (OMCL) shares were granted to the CFO and at what price?

The CFO was granted 32,932 shares of Omnicell common stock in the form of RSUs, reported with a transaction price of $0 per share, indicating a compensatory grant rather than an open-market purchase.

What is the vesting schedule for the 32,932 Omnicell (OMCL) restricted stock units?

According to the filing, 25% of the RSUs vest on November 15, 2026. The remaining 75% vest quarterly over three years on 2/15, 5/15, 8/15, and 11/15, as long as the vesting conditions are met.

How many Omnicell (OMCL) shares does the reporting person beneficially own after this transaction?

Following the reported grant, the filing states that H. Baird Radford III beneficially owns 32,932 shares of Omnicell common stock, held in direct ownership form.

What is the role of the reporting person in Omnicell (OMCL)?

The reporting person is identified as an Officer of Omnicell, holding the title of EVP & Chief Financial Officer, and is not listed as a director or 10% owner in this filing.

Is this Omnicell (OMCL) Form 4 filed for an individual or a group?

The document indicates that it is a Form filed by One Reporting Person, meaning it only covers transactions for H. Baird Radford III and not for a group of filers.

Omnicell Com

NASDAQ:OMCL

OMCL Rankings

OMCL Latest News

OMCL Latest SEC Filings

OMCL Stock Data

1.55B
44.02M
1.79%
105.72%
4.22%
Health Information Services
Electronic Computers
Link
United States
FORT WORTH